IL6 and COVID-19: The diagnosis is based on the history of coronavirus disease (COVID-19) or virus exposure (confirmed with antibody tests), specific clinical symptoms (high fever, abdominal discomfort/pain, skin rash, conjunctivitis, fatigue), and elevated levels of inflammatory markers, similar to those reported in a “cytokine storm” in an adult’s COVID-19, predominantly interleukin-6 (IL-6) [4].